Hydralazine
Hydralazine
Arteriolar Vasodilator
NADAC/unit
$0.0269
Active Shortage
Tier 1: 259.9%
17 Manufacturers
42 ANDAs
INDICATIONS AND USAGE Essential hypertension, alone or as an adjunct.
vs. brand Hydralazine: Generic saves up to 100% per unit
Active Shortages
2020-04-07 Shortage reported, Meitheal Pharmaceuticals, Inc.
Market Intelligence
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
Generic Manufacturers
ALKEM LABORATORIES LTDAMERICAN REGENT INCBAXTER HEALTHCARE CORPCADILA PHARMACEUTICALS LTDEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLENMARK PHARMACEUTICALS LTDHERITAGE PHARMACEUTICALS INCHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCHETERO LABS LTD UNIT IIIHIKMA PHARMACEUTICALS USA INCKINDOS PHARMACEUTICALS CO LTDNAVINTA LLCPLIVA INCRISING PHARMA HOLDINGS INCSCIEGEN PHARMACEUTICALS INCSTRIDES PHARMA GLOBAL PTE LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.